Home › NDC Lookup › Ingredients › Acetaldehyde, Dopamine Hydrochloride, Dh... › 62185-0050-01
Hormone Balance Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating H 6 [hp_X]/mL; 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL Liquid, 30 mL — NDC 62185-0050-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Hormone Balance Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating H 6 [hp_X]/mL; 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL Liquid, 30 mL — NDC 62185-0050-1 (Billing 62185-0050-01)

by Dr. Donna Restivo DC · 30 mL in 1 BOTTLE, DROPPER

This is a package of 30 mL of Hormone Balance Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating H 6 [hp_X]/mL; 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL Liquid from Dr. Donna Restivo DC, marketed since Sep 2019 and currently FDA-listed, this package's marketing is listed to end Mar 2027. It is this product's only package size.

NDC 62185-0050-01
🏷️ FDA NDC (as labeled) 62185-0050-1 billing pads the package segment with a zero
OTC On market CIII ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 62185-0050-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
62185 labeler · 0050 product · 1 package
Package marketed since
Sep 3, 2019
Package marketing ended
Mar 1, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 6218500501 1
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 62185-0050-1
Product NDC 62185-0050
11-digit billing NDC 62185005001
UNII GO1N1ZPR3B, 7L3E358N9L, 84RQ0XOM11, 2DI9HA706A, S7YTV04R8O, 97C5T2UQ7J +6 more
SPL Set ID 421707d6-31c1-4d57-b017-796fc872efe4
Established class (EPC) Progesterone; Androgen; Gonadotropin
Mechanism of action Androgen Receptor Agonists
Chemical class Progesterone; Androstanes; Gonadotropins
DEA schedule CIII
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-09-03
Marketing end 2027-03-01
Route ORAL
Dosage form LIQUID
Substance ACETALDEHYDE; DOPAMINE HYDROCHLORIDE; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ESTRONE; SUS SCROFA OVARY; CHOLESTEROL; PROGESTERONE; TESTOSTERONE; CORTISONE ACETATE; ALDOSTERONE; ANDROSTERONE; FOLLITROPIN
Why two NDCs? The FDA registers this code as 62185-0050-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 62185-0050-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an unapproved homeopathic liquid taken by mouth that contains multiple ingredients traditionally associated with hormones and hormone-like substances. The product lists substances such as progesterone, testosterone, estrone, and DHEA, which in conventional medicine are hormones involved in reproductive and metabolic function, along with dopamine (a brain chemical) and various other hormone-related compounds. Homeopathic products are marketed based on homeopathic tradition and have not been evaluated by the FDA for safety or effectiveness. This listing appears in the unapproved homeopathic category.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
62185-0050-01 You're viewing this Main listing 30 mL in 1 BOTTLE, DROPPER 2019-09-03 Mar 1, 2027 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Hormone Balance 6 [hp_X]/mL; 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mLthis 62185-0050-01 Dr. 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Sep 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesdemineralized water, 25% ethanol.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDr. Donna Restivo DC
Labeler code62185
First marketedSep 2019
DEA scheduleCIII
Product typeHuman Otc Drug
Portfolio19 products on file

More NDCs from Dr. Donna Restivo DC labeler code 62185

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 56 words ▾

HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances or insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females) and lack of libido.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

⏱️ Dosage and Administration 31 words ▾

DIRECTIONS: 10 drops under the tongue, 3 to 6 times per day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

⚠️ Warnings 48 words ▾

WARNINGS: Keep out of reach of children. In case of overdose, get medical help or contact or a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use. Tamper seal: "Sealed for Your Protection." Do not use if seal is broken or missing.

🧪 Active Ingredient 107 words ▾

ACTIVE INGREDIENTS: Acetaldehyde 6X, 12X, 30X, 200X, Dopamine Hydrochloride 6X, 12X, 30X, 200X, DHEA (Dehydroepiandrosterone) 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, 7-Oxo-Dehydroepiandrosterone 3-Acetate 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Folliculinum 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Oophorinum (Suis) 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Cholesterinum 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C,Progesterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Testosterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Cortisone Aceticum 12X, 30X, 200X, 12C, 30C, 60C, 200C, Aldosterone 12C, 30C, 60C, 200C, Androsterone 12C, 30C, 60C, 200C, Follicle Stimulating Hormone 12C, 30C, 60C, 200C.

🧪 Inactive Ingredients 6 words ▾

INACTIVE INGREDIENTS: demineralized water, 25% ethanol.

🎯 Purpose 56 words ▾

HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances or insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females) and lack of libido.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

📄 Keep Out of Reach of Children 28 words ▾

KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact or a Poison Control Center right away.

📄 Questions or Comments 21 words ▾

QUESTIONS: Distributed by Dr. Donna Restivo DC, Wellness Consultant 822 South Lake Blvd, Mahopac, New York 10541 www.mahopacmassage.com • (845) 628-6286

📄 Package Label / Principal Display Panel 21 words ▾

PACKAGE LABEL DISPLAY: DR. DONNA RESTIVO DC WELLNESS CONSULTANT NDC 62185-0041-1 HOMEOPATHIC Hormone Balance 1 FL OZ (30 ml) Hormone Balance

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Hormone Balance (this brand).

Top reported reactions

Chills1
Dizziness1
Fatigue1
Headache1
Hyperhidrosis1
Nausea1
Pyrexia1

Reporter sex

1 reports
Female · 100%
Reports over time (by year) — tap or hover for the count & year
2023 2024 2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Hormone Balance Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating H 6 [hp_X]/mL; 6 [hp_X]/mL; 7-OXODEHYDROEPIANDROSTERONE 3-ACETATE 6 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL; 8 [hp_X]/mL LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Dr. Donna Restivo DC has reported a marketing end date of 2027-03-01, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Dr. Donna Restivo DC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 62185-0047-01 · Dr. 62185-0051-01 · Dr. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.